# TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion

Study · id `cardio:ct-nct03596385` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03596385](<https://clinicaltrials.gov/study/NCT03596385>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03596385

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 8505 participants.

## Technical summary

Registry record NCT03596385. Randomized; no masking; primary purpose treatment. Start 2018-10-31 (actual); primary completion 2025-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 8505 participants (enrolled count; ClinicalTrials.gov record NCT03596385, source copy `cardio:ctgov-nct03596385-2025-06-06`, retrieved 2026-10-26)
- Started: 2018-10-31 (actual) (ClinicalTrials.gov record NCT03596385, source copy `cardio:ctgov-nct03596385-2025-06-06`, retrieved 2026-10-26)
- Primary completion: 2025-01-31 (actual) (ClinicalTrials.gov record NCT03596385, source copy `cardio:ctgov-nct03596385-2025-06-06`, retrieved 2026-10-26)
- Completion: 2025-01-31 (actual) (ClinicalTrials.gov record NCT03596385, source copy `cardio:ctgov-nct03596385-2025-06-06`, retrieved 2026-10-26)
- Countries: Italy; Spain (ClinicalTrials.gov record NCT03596385, source copy `cardio:ctgov-nct03596385-2025-06-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03596385-2025-06-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"
- Condition: Myocardial Infarction
- Intervention (Drug): Beta blocker
- Lead sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Beta-blockers (drug class) (`cardio:beta-blockers`)
- Registry lists this organization as the lead sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (`cardio:org-fundacion-centro-nacional-de-investigaciones-0f9f16`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (`cardio:pubmed-40888702`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trial (`cardio:pubmed-42034335`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 668323cae480dadd948102297570da4f47ba1daff0e1f80fa046d73d858888fc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
